Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 7,586,312 $ 10,950,927
Prepaid expenses and other current assets 398,874 554,321
Australia research and development incentives receivable 348,379 302,789
Total current assets 8,333,565 11,808,037
Deferred offering costs 737,688 211,203
Other assets 2,800 2,800
Total assets 9,074,053 12,022,040
Current liabilities:    
Accounts payable 1,127,412 1,165,505
Accrued expenses 2,639,034 2,103,401
Total current liabilities 3,766,446 3,268,906
Long term liabilities:    
Warrant liability 224,399 245,341
Total liabilities 3,990,845 3,514,247
Commitments and contingencies (Note 5)
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at March 31, 2023 and December 31, 2022, 0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 shares authorized at March 31, 2023 and December 31, 2022, 10,996,404 and 10,955,904 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 1,100 1,096
Additional paid-in capital 53,431,530 52,729,942
Accumulated deficit (48,324,148) (44,207,272)
Accumulated other comprehensive loss (25,274) (15,973)
Total stockholders' equity 5,083,208 8,507,793
Total liabilities and stockholders' equity $ 9,074,053 $ 12,022,040